|
|
???tair.name??? >
???browser.page.title.author???
|
"choi h j"???jsp.browse.items-by-author.description???
Showing items 1-9 of 9 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2022-08-19T00:20:47Z |
A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma
|
Tak W.Y.; Yen C.-J.; Jeffers M.; Krissel H.; Kappeler C.; Rajagopalan P.; Hsieh W.-S.; Tay M.H.; Yeo W.; Park J.-W.; Poon R.T.P.; Rau K.-M.; CHIUN HSU; Yoon J.-H.; Lin C.-Y.; Choi H.J.; Heo J.; Lim H.Y. |
| 臺大學術典藏 |
2021-08-31T06:29:13Z |
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
|
Ryoo B.-Y.; ANN-LII CHENG; Ren Z.; Kim T.-Y.; Pan H.; Rau K.-M.; Choi H.J.; Park J.-W.; Kim J.H.; Yen C.J.; Lim H.Y.; Zhou D.; Straub J.; Scheele J.; Berghoff K.; Qin S. |
| 國立成功大學 |
2021 |
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
|
Ryoo, B.-Y.;Cheng, A.-L.;Ren, Z.;Kim, T.-Y.;Pan, H.;Rau, K.-M.;Choi, H.J.;Park, J.-W.;Kim, J.H.;Yen, C.J.;Lim, H.Y.;Zhou, D.;Straub, J.;Scheele, J.;Berghoff, K.;Qin, S. |
| 臺大學術典藏 |
2020-06-11T06:31:12Z |
Speckle noise reduction on a laser projection display via a broadband green light source
|
Yu, N.E.;Choi, J.W.;Kang, H.;Ko, D.-K.;Fu, S.-H.;Liou, J.-W.;Kung, A.H.;Choi, H.J.;Kim, B.J.;Cha, M.;Peng, L.-H.; Yu, N.E.; Choi, J.W.; Kang, H.; Ko, D.-K.; Fu, S.-H.; Liou, J.-W.; Kung, A.H.; Choi, H.J.; Kim, B.J.; Cha, M.; Peng, L.-H.; LUNG-HAN PENG |
| 臺大學術典藏 |
2020-05-25T07:35:06Z |
An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma
|
Abou-Alfa G.K.;Yau T;Ryoo B.-Y;Knox J;Brown J;Kelley R.K;Chao T.-Y;Choi H.J;Freilich B;Modiano M;Yoon J.-H;Chia-Chi Lin;Yong W.P;Lim H.Y;El Dika I; El Dika I; Lim H.Y; Yong W.P; Chia-Chi Lin; Yoon J.-H; Modiano M; Freilich B; Choi H.J; Chao T.-Y; Kelley R.K; Brown J; Knox J; Ryoo B.-Y; Yau T; Abou-Alfa G.K. |
| 臺大學術典藏 |
2020-04-10T12:51:06Z |
A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma
|
Lim H.Y.; Heo J.; Choi H.J.; Lin C.-Y.; Yoon J.-H.; Chiun Hsu; Rau K.-M.; Poon R.T.P.; Yeo W.; Park J.-W.; Tay M.H.; Hsieh W.-S.; Kappeler C.; Rajagopalan P.; Krissel H.; Jeffers M.; Yen C.-J.; Tak W.Y. |
| 國立成功大學 |
2020 |
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study
|
Bang, Y.-J.;Li, C.-P.;Lee, K.-H.;Chiu, Chiu C.-F.;Park, J.O.;Shan, Y.-S.;Kim, J.S.;Chen, J.-S.;Shim, H.-J.;Rau, K.-M.;Choi, H.J.;Oh, D.-Y.;Belanger, Belanger B.;Chen, L.-T. |
| 國立成功大學 |
2020 |
Phase i study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer
|
Yoo, C.;Oh, D.-Y.;Choi, H.J.;Kudo, M.;Ueno, M.;Kondo, S.;Chen, L.-T.;Osada, M.;Helwig, C.;Dussault, I.;Ikeda, M. |
| 國立臺灣科技大學 |
2015 |
Hopping conduction in p -type MoS2 near the critical regime of the metal-insulator transition
|
Park, T.-E.;Suh, J.;Seo, D.;Park, J.;Lin, D.-Y.;Huang, Y.-S.;Choi, H.-J.;Wu, J.;Jang, C.;Chang, J. |
Showing items 1-9 of 9 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
